Rathbone Daniel L, Parker Katy J, Coleman Michael D, Lambert Peter A, Billington David C
School of Life and Health Sciences, Aston University, Birmingham B4 7ET, UK.
Bioorg Med Chem Lett. 2006 Feb 15;16(4):879-83. doi: 10.1016/j.bmcl.2005.11.005. Epub 2005 Nov 18.
As part of a study into antimycobacterial compounds a set of phenolic N1-benzylidene-pyridinecarboxamidrazones was prepared and evaluated. This report describes the unexpected discovery of a potent compound with a pronounced selectivity for Gram-positive bacteria over Gram-negative micro-organisms. In addition, this compound is active against various drug-resistant Gram-positive bacteria.
作为一项抗分枝杆菌化合物研究的一部分,制备并评估了一组酚类N1-亚苄基吡啶甲脒。本报告描述了一种强效化合物的意外发现,该化合物对革兰氏阳性菌具有明显优于革兰氏阴性微生物的选择性。此外,该化合物对多种耐药革兰氏阳性菌具有活性。